相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies
Rocky Cipriano et al.
ONCOTARGET (2013)
FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice
Sun-Young Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
FAM83B mediates EGFR- and RAS-driven oncogenic transformation
Rocky Cipriano et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Phospholipase D: Enzymology, Functionality, and Chemical Modulation
Paige E. Selvy et al.
CHEMICAL REVIEWS (2011)
Inactivation of p53 signaling by p73 or PTEN ablation results in a transformed phenotype that remains susceptible to nutlin-3 mediated apoptosis
Rocky Cipriano et al.
CELL CYCLE (2010)
Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells
David A. Foster
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
Farrah Kassam et al.
CLINICAL BREAST CANCER (2009)
Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin
Alfredo Toschi et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness
Sarah A. Scott et al.
NATURE CHEMICAL BIOLOGY (2009)
Role of Phosphatidic Acid in the Coupling of the ERK Cascade
Catherine A. Kraft et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cotargeting survival signaling pathways in cancer (vol 118 pg 3003, 2008)
Steven Grant
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras
Ming Shi et al.
CANCER LETTERS (2007)
P53-mediated growth suppression in response to Nutlin-3 in cyclin D1-transformed cells occurs independently of p2l
Charlene E. Kan et al.
CANCER RESEARCH (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
RaIB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival
Yuchen Chien et al.
CELL (2006)
Levels of HdmX expression dictate the sensitivity of normal and transformed cells to nutlin-3
JT Patton et al.
CANCER RESEARCH (2006)
Requirement of phospholipase D1 activity in H-RasV12-induced transformation
FG Buchanan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Species- and cell type-specific requirements for cellular transformation
A Rangarajan et al.
CANCER CELL (2004)
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53
MW Jackson et al.
ONCOGENE (2004)
New targets for therapy in breast cancer - Mammalian target of rapamycin (mTOR) antagonists
H Carraway et al.
BREAST CANCER RESEARCH (2004)
Phospholipase D confers rapamycin resistance in human breast cancer cells
YH Chen et al.
ONCOGENE (2003)
Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2
T Joseph et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
RalA mediates v-Src, v-Ras, and v-Raf regulation of CD44 and fibronectin expression in NIH3T3 fibroblasts
V Ladeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Overexpression of phospholipase D1 in human breast cancer tissues
DY Noh et al.
CANCER LETTERS (2000)
The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras
MA Rizzo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
